![]() |
| Kathryn Metcalfe |
Bristol-Myers Squibb has named healthcare PR veteran Kathryn Metcalfe executive VP, corporate affairs, effective Jan. 6.
Metcalfe goes to BMS from CVS Health, where she was chief communications officer. She previously served as CCO at both Aetna and Deloitte, held VP posts at Pfizer and Novartis and helmed Cohn & Wolfe's New York office.
Metcalfe “will play an important role on the leadership team as we engage with a broad range of stakeholders around our business, the promise of our pipeline and the exciting opportunities we are pursuing for patients,” said BMS chief and CEO Giovanni Caforio.
Metcalfe’s appointment follows the announcement that BMS executive VP, corporate affairs & investor relations John Elicker will be retiring on March 31.
Tim Power, who is currently lead for IR, will take on the position of VP & IR chief upon Elicker’s retirement.


Even as technology changes the rules of engagement, digital health brands still control the most powerful tool they have—their story.
Havilah Clarke, head of marketing and communications at the Huntsman Mental Health Foundation and Institute, has joined Purposeful Advisors as a managing director.
How purpose-driven communications strengthens reputation, rallies stakeholders and builds value during economically turbulent times.
Why healthcare must prioritize more strategic communications integration.



